Refining the Approach to Risk Stratification in Patients With Dilated Cardiomyopathy

J Am Coll Cardiol. 2021 Jun 15;77(23):2906-2908. doi: 10.1016/j.jacc.2021.04.031.

Authors

Anne B Curtis¹, Hassan A Khan²

Affiliations

¹ Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA. Electronic address: abcurtis@buffalo.edu.
² Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.

PMID: 34112318
DOI: 10.1016/j.jacc.2021.04.031

No abstract available

Keywords: cardiomyopathy; implantable cardioverter defibrillator; risk stratification; sudden cardiac death.

Publication types

Editorial
Comment

MeSH terms

Cardiomyopathy, Dilated* / diagnosis
Cardiomyopathy, Dilated* / epidemiology
Cardiomyopathy, Dilated* / therapy
Death, Sudden, Cardiac
Defibrillators, Implantable*
Humans
Risk Assessment